Why BGPT?
logo

Aggregated Evidence

Compile and compare specific findings across multiple studies into unified evidence records.Know what the science actually supports before you trust the answer.

Press Enter ↡ to analyze aggregation


     Quick Analysis Plan



    The supplied evidence contains no vitamin D supplementation RCTs for infectious disease outcomes, so the core meta-analysis data are missing; available records only support baseline-deficiency context (e.g., 60.2% deficiency <20 ng/mL in Karachi; mean 49.44 nmol/L in Tianjin) .


     Long Analysis Plan



    Missing Critical Evidence

    The claim-level records supplied contain zero vitamin D supplementation RCTs with infectious disease outcomes β€” they cover alopecia, cardiac autonomic function, HVDRR immunity, breast cancer, kidney transplantation, and population deficiency prevalence. A heterogeneity meta-analysis by baseline deficiency subgroups cannot be executed from these data. What the records do support is subgroup-definition context: deficiency is highly prevalent across diverse populations (Karachi 60.2% <20 ng/mL; Tianjin mean 49.44 nmol/L), and seasonality materially shifts baseline status (winter 17.4 vs summer 20.2 ng/mL in transplant recipients), which any subgroup analysis must adjust for . The required missing inputs are: the actual RCT set (e.g., trial-level effect sizes for respiratory/other infections), baseline 25(OH)D strata per arm, and event counts per subgroup.



    Feedback:    

    Updated: October 25, 2026



     Top Data Sources ExportMCP



     Hypothesis Graveyard



    Vitamin D uniformly reduces infection risk across all RCTs β€” falsified pattern in prior literature where replete populations show null effects; heterogeneity must be modeled, not pooled.

     Science Art


    Meta-analysis: Vitamin D supplementation infectious disease RCT heterogeneity baseline deficiency subgroups Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT